Innovative Updates to the Brevera® Breast Biopsy System with CorLumina® Imaging Technology Are Introduced by Hologic

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

August 28, 2020: Hologic, Inc. an innovative medical technology company primarily focused on improving women’s health, today announced improvements to the Brevera® Breast Biopsy System with CorLumina® Imaging Technology, the world’s first and only breast biopsy solution to combine vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one, integrated system.

Since its launch in 2017, the Brevera system has shifted the way clinicians perform breast biopsies and verify that the targeted tissue samples have been acquired. The system streamlines the entire biopsy process from start to finish – with real-time imaging for verification of sample acquisition and automated post-biopsy specimen handling.  These integrated features offer the potential to save facilities an average of 13 minutes per procedure2 to transform the patient experience and enhance workflow. In addition, they allow clinicians to remain by the patient’s side during the entire procedure, eliminating the need to leave the room to image and verify tissue samples, which often leads to lengthy procedure times and anxious patients, as well as interruptions to facility screening schedules.

“As a world leader in breast health, we take great pride in our commitment to constant innovation – informed by clinical research and customer feedback – to continuously expand and improve upon the performance of our products,” said Jennifer Meade, Hologic’s Division President, Breast and Skeletal Health Solutions. “The launch of the Brevera system represented a major transformation in breast biopsy, and we’re confident that the improvements we’ve introduced will further the system’s ability to enhance workflow, increase accuracy and improve the overall patient experience.”

To better meet clinician needs, the Brevera system features a reusable device driver and disposable needles to simplify storage and improve waste management.1 The system also features improvements that allow radiologists and technologists to better separate and verify target samples automatically, then transfer seamlessly to pathology with minimal handling to help maintain core integrity.

The Brevera system is designed for use with Hologic’s Affirm® Prone biopsy guidance system. When paired together, the Brevera system and Affirm® system accelerate the speed and efficiency of prone biopsy procedures to further reduce the patient’s time under compression.[2]


References:

[1] Compared to Eviva® device. Hologic Data on file 2017.

2 Brevera Pulse Survey, Quantitative report. Inspired Insights. April 2019

[2] Results from, “A Prospective, Block Stratified Clinical Trial to Evaluate the Performance and Operation of the Brevera® Breast Biopsy System” (NCT03300206) (US)

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.